COMMUNIQUÉS West-GlobeNewswire

Bradmer Announces First Quarter 2018 Financial Results

31/05/2018 - 01:04

TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- Bradmer Pharmaceuticals Inc. (TSX VENTURE:BMR.H) (“Bradmer” or the “Company”) today announced its first quarter 2018 financial results. Financial Results Amounts in US dollars, [...]

Mesoblast Appoints New Chief Financial Officer

31/05/2018 - 00:41

MELBOURNE, Australia and NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq: MESO ) today announced the appointment of Josh Muntner as its new Chief Financial Officer, based in New York. [...]

Akers Biosciences Granted 180-Day Extension by Nasdaq to Meet Minimum Bid Price Requirement

31/05/2018 - 00:09

THOROFARE, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces that, on May 30, [...]

Helix BioPharma Corp. Completes Third Dosing Cohort and Initiates Enrollment of the Next Cohort in U.S. Combination Treatment Study of Its Lung Cancer Drug Candidate L-DOS47

30/05/2018 - 23:05

RICHMOND HILL, Ontario, May 30, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP ) (FSE:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and [...]

Revive Therapeutics Announces Results for the Three and Nine Months Ended March 31, 2018

30/05/2018 - 23:00

TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the " Company ") (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel [...]

IMV Leadership to Participate in Upcoming Investor and Business Development Conferences

30/05/2018 - 22:35

HALIFAX, Nova Scotia, May 30, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (TSX: IMV ) (OTCQX:IMMVD), a clinical stage immuno-oncology company, today announced details on upcoming industry presentations that the company’s [...]

AIT Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference

30/05/2018 - 22:30

NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTC:AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients [...]

CRISPR Therapeutics and Vertex Provide Update on FDA Review of Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease

30/05/2018 - 22:30

BOSTON and ZUG, Switzerland and CAMBRIDGE, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ) and Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) today announced that the U.S. Food and Drug [...]

Corvus Pharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference

30/05/2018 - 22:15

BURLINGAME, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS ), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]

Inspire Medical Systems, Inc. to Present at the Goldman Sachs 39th Annual Global Healthcare Conference

30/05/2018 - 22:05

MINNEAPOLIS, May 30, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP ) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]

Denali Therapeutics Announces Early Exercise of Its Option to Acquire F-star Gamma

30/05/2018 - 22:05

SOUTH SAN FRANCISCO, May 30, 2018 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI ), a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases, today [...]

Medigus to Present New Data On The MUSE™ System at Digestive Disease Week® (DDW) 2018

30/05/2018 - 22:05

OMER, Israel, May 30, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS ) (TASE: MDGS ), a medical device company developing minimally invasive endosurgical tools and an innovator in direct visualization technology, [...]

Golden Leaf Reports Fiscal First Quarter 2018 Results

30/05/2018 - 22:05

TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company and dispensary operator built around recognized [...]

GILEAD AND GALAPAGOS ANNOUNCE RESULTS WITH FILGOTINIB IN THE PHASE 2 EQUATOR STUDY IN PSORIATIC ARTHRITIS AND PROGRESSION INTO PHASE 3 FOR THE SELECTION STUDY IN ULCERATIVE COLITIS

30/05/2018 - 22:02

-- EQUATOR Achieves Primary Endpoint of ACR20 Response at Week 16 -- -- Galapagos to Receive $15 Million Payment from Gilead for Progression into Phase 3 of the Phase 2b/3 SELECTION Study of Filgotinib in Ulcerative [...]

Ascendis Pharma A/S Reports First Quarter 2018 Financial Results

30/05/2018 - 22:02

- Continued execution and achievement of planned milestones across three wholly-owned clinical programs in rare endocrine diseases - - Conference Call Today at 4:30 p.m. Eastern Time - COPENHAGEN, Denmark, May 30, 2018 [...]

Dermira to Present at Jefferies 2018 Global Healthcare Conference

30/05/2018 - 22:01

MENLO PARK, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]

Trevena to Present at the Jefferies Global Healthcare Conference

30/05/2018 - 22:01

CHESTERBROOK, Pa., May 30, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced that it will be presenting at the Jefferies Global Healthcare Conference on Wednesday, June 6 th , 2018, at 3:30 p.m. EDT [...]

Collegium to Present at Upcoming Investor Conferences

30/05/2018 - 22:01

CANTON, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL ) today announced that management will present at the following investor conferences in June: The Jefferies Global Healthcare [...]

Vericel Corporation Announces Proposed Public Offering of Common Stock

30/05/2018 - 22:01

CAMBRIDGE, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that it intends to offer [...]